# A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB

> **NCT02615639** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 450 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **BIOLOGICAL:** HPDC-T cells & Entecavir
- **DRUG:** Entecavir
- **DRUG:** HPDC-T cells & IFN-a-2a
- **DRUG:** IFN-a-2a
- **DRUG:** HPDC-T cells & Telbivudine
- **DRUG:** Telbivudine

## Key facts

- **NCT ID:** NCT02615639
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2015-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615639, "A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02615639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*